Pharmacokinetics of ofloxacin--measurement of drug concentration in saliva of patients with impaired renal function. 1995

K Fujita, and N Matsuoka, and I Takenaka, and K Hiraishi, and T Yokota, and T Asahi, and K Tatara, and M Yuasa, and Y Kaifu, and A Kawano
Kagawa Medical School, Japan.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection
D015242 Ofloxacin A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. DL-8280,DR-3355,Hoe-280,ORF-28489,Ofloxacin Hydrochloride,Ofloxacine,Ru-43280,Tarivid,DL 8280,DL8280,DR 3355,DR3355,Hoe 280,Hoe280,ORF 28489,ORF28489,Ru 43280,Ru43280

Related Publications

K Fujita, and N Matsuoka, and I Takenaka, and K Hiraishi, and T Yokota, and T Asahi, and K Tatara, and M Yuasa, and Y Kaifu, and A Kawano
January 1987, Drugs,
K Fujita, and N Matsuoka, and I Takenaka, and K Hiraishi, and T Yokota, and T Asahi, and K Tatara, and M Yuasa, and Y Kaifu, and A Kawano
September 1982, The Journal of antimicrobial chemotherapy,
K Fujita, and N Matsuoka, and I Takenaka, and K Hiraishi, and T Yokota, and T Asahi, and K Tatara, and M Yuasa, and Y Kaifu, and A Kawano
November 1976, The Journal of infectious diseases,
K Fujita, and N Matsuoka, and I Takenaka, and K Hiraishi, and T Yokota, and T Asahi, and K Tatara, and M Yuasa, and Y Kaifu, and A Kawano
January 1988, Drugs under experimental and clinical research,
K Fujita, and N Matsuoka, and I Takenaka, and K Hiraishi, and T Yokota, and T Asahi, and K Tatara, and M Yuasa, and Y Kaifu, and A Kawano
April 1993, Antimicrobial agents and chemotherapy,
K Fujita, and N Matsuoka, and I Takenaka, and K Hiraishi, and T Yokota, and T Asahi, and K Tatara, and M Yuasa, and Y Kaifu, and A Kawano
October 1986, The Japanese journal of antibiotics,
K Fujita, and N Matsuoka, and I Takenaka, and K Hiraishi, and T Yokota, and T Asahi, and K Tatara, and M Yuasa, and Y Kaifu, and A Kawano
January 1990, Drugs,
K Fujita, and N Matsuoka, and I Takenaka, and K Hiraishi, and T Yokota, and T Asahi, and K Tatara, and M Yuasa, and Y Kaifu, and A Kawano
January 1986, European journal of clinical pharmacology,
K Fujita, and N Matsuoka, and I Takenaka, and K Hiraishi, and T Yokota, and T Asahi, and K Tatara, and M Yuasa, and Y Kaifu, and A Kawano
January 1989, British journal of clinical pharmacology,
K Fujita, and N Matsuoka, and I Takenaka, and K Hiraishi, and T Yokota, and T Asahi, and K Tatara, and M Yuasa, and Y Kaifu, and A Kawano
January 1992, European journal of clinical pharmacology,
Copied contents to your clipboard!